Business Context and Reporting Period
Company: Village Farms International, Inc. (VFF)
Filing Type: Form 10-Q (Unaudited)
Period Ended: September 30, 2025
Business Overview: VFF operates in five segments: Cannabis-Canada (Pure Sunfarms, Rose LifeScience), Cannabis-U.S. (Balanced Health), Cannabis-Netherlands (Leli Holland), Produce (VFCLP), and Clean Energy. The company recently privatized a portion of its Produce segment via a transaction with Vanguard Food LP, classifying those assets as discontinued operations.
Key Financial Metrics
| Metric | Three Months Ended Sept 30, 2025 | Nine Months Ended Sept 30, 2025 |
|---|---|---|
| Total Revenue | $66.7 million | $166.3 million |
| Gross Profit | $31.9 million (47.9% margin) | $68.5 million (41.2% margin) |
| Net Income (Attributable to Shareholders) | $10.2 million | $30.0 million |
| Adjusted EBITDA | $20.3 million | $33.6 million |
| Cash and Cash Equivalents | $82.6 million | $82.6 million (Balance Sheet) |
| Total Debt (Current + Long-Term) | $34.6 million | $34.6 million |
| Working Capital | $100.2 million | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 21% quarter-over-quarter (QoQ) and 10% year-over-year (YoY) for the nine-month period. Growth was driven by a 28% increase in Canadian Cannabis sales (due to international exports) and the inclusion of Leli Holland (Netherlands) sales, which commenced in Q1 2025.
- Profitability Surge: Net income turned from a loss of $0.8 million in Q3 2024 to a profit of $10.2 million in Q3 2025. For the nine months, the company reported a net income of $30.0 million compared to a net loss of $27.2 million in the prior year.
- Discontinued Operations: The sale of certain Produce assets to Vanguard Food LP resulted in a one-time gain of approximately $20.0 million, significantly impacting the nine-month net income. Operating results for these assets are now classified as discontinued.
- Impairments: Unlike the prior year, which included a $11.9 million goodwill and intangible impairment charge in the U.S. Cannabis segment, no impairments were recorded in the current period.
- Debt Restructuring: In April 2025, the company replaced several existing credit facilities with new "Pure Sunfarms Secured Credit Facilities" and amended its FCC Term Loan to include more favorable covenants.
Guidance, Outlook, and Risks
- Canadian Cannabis: Management reports maintaining a top-five market share in Canada. International export sales increased 758% YoY, driven by demand in Germany. The company is expanding cultivation capacity at the Delta 2 greenhouse to meet demand.
- Netherlands (Leli): Phase I operations are at full capacity with products in 91% of participating coffeeshops. Phase II construction is on track for Q1 2026, expected to quintuple production capacity.
- U.S. Cannabis: Sales declined due to state regulatory restrictions and unregulated hemp competition. A Texas medicinal marijuana license application is pending, with a decision expected December 1, 2025.
- Liquidity: The company holds $87.6 million in cash and restricted cash. Management believes existing cash and operating cash flow are sufficient for the next 12 months. A $10 million share repurchase program was authorized in September 2025, though no shares have been purchased yet.
- Risks: Key risks include regulatory changes in the U.S. and Canada, foreign exchange fluctuations (CAD/USD), reliance on credit facilities, and the uncertainty of realizing benefits from the Vanguard Food LP transaction.
Investor Verification Checklist
- Discontinued Operations Impact: Verify the sustainability of earnings by excluding the ~$20 million one-time gain from the Produce asset sale.
- International Export Growth: Confirm the durability of the 758% increase in international medical cannabis exports, particularly to Germany.
- Debt Covenants: Review the specific terms of the new Pure Sunfarms Secured Credit Facilities and the amended FCC Term Loan to ensure ongoing compliance with financial covenants.
- U.S. Regulatory Status: Monitor the status of the Texas medicinal marijuana license application and potential impacts of state-level CBD restrictions.
- Share Repurchase Execution: Track whether the company proceeds with the authorized $10 million share buyback program.